The Highest Standard in Peptide Research.

Bodytide Wellness Lab
WEIGHT MANAGEMENT & METABOLIC OPTIMISATION

AOD9604 10MG

Targeted fat breakdown without glycemic spikes

AOD9604 is a modified peptide fragment of human growth hormone (C-terminus 176-191) engineered to stimulate lipolysis and inhibit lipogenesis without affecting insulin pathways.

AOD9604 10MG
£129.00

Active Ingredient: 10.00mg per pen

Volume: 3.00ml

For in vitro use only.

Typical research suggests 5 clicks daily, weeks 1-2. Then 10 clicks daily thereafter.

All our Peptide Pens are designed to last a minimum of 30 days.

Taxes included. Shipping calculated at checkout.

Current batch fully reserved. Next allocation underway.

Expected Benefits

By combining clinical research with day-to-day wellness support, this protocol offers clear metabolic improvements:

Targeted Fat Breakdown: Triggers lipolysis directly in stubborn subcutaneous and visceral fat deposits.
Zero Glycemic Impact: Burns fat without disrupting blood glucose levels or insulin sensitivity.
Inhibited Fat Storage: Blocks lipogenesis, preventing excess dietary energy from converting into new adipose tissue.
Cartilage Support: Preclinical data indicates regenerative actions on joint cartilage repair.
High Tolerability: Free from the systemic side effects typically seen with full-sequence GH.

Manufactured and tested to
pharmaceutical standards

EU GMP ISO 9001 ISO 13485 ISO 14644
To maintain the integrity of your protocol, correct storage is essential. Always store your Peptide pen in its protective casing within the refrigerator, strictly between 2°C and 8°C. Ensure the pen is shielded from direct light and never allowed to freeze. When travelling, we recommend utilizing a temperature-controlled travel case.

What is AOD9604 10MG?

AOD9604 was developed by researchers looking to isolate the fat-burning properties of growth hormone from its anabolic effects. It selectively triggers beta-3 adrenergic receptors on adipocytes, stimulating the breakdown of stored triglycerides without raising blood sugar or IGF-1 levels.

The Cellular Mechanism

Beta-3 Receptor Agonism: Stimulates lipolytic cascade within adipose cells via cyclic AMP upregulation.
Lipogenesis Inhibition: Blocks the activity of enzymes responsible for converting calories into stored fatty acids.

Protocol Schedule

Clinical evaluation studies show that a typical research protocol ranges from 250mcg to 500mcg daily, administered in the morning on an empty stomach. To allow cellular receptors to adapt comfortably, researchers follow a step-by-step escalation schedule:

Weeks 1-2 (Baseline Priming): An initial daily dose of 250mcg (5 clicks once per day).

Weeks 2 Onwards (Active Titration): The protocol scales to 500mcg daily (10 clicks once per day).

Once targets are achieved, dosage can be reviewed and adjusted according to results.

Possible Side Effects

Mild Flushing: Brief, transient feeling of warmth immediately after application.
Site Pinkness: Minor, short-lived redness at the application site.